Cardiovascular system pharmaceuticals market revenue in Argentina 2017-2022
In the fourth quarter of 2022, the revenue of the cardiovascular system pharmaceutical industry in Argentina amounted to over 33 billion Argentine pesos, up from around 29.1 billion pesos reported in the previous quarter. The market revenue of pharmaceuticals for the cardiovascular system in the South American country has been increasing since the first quarter of 2020, when it amounted to more than eight billion pesos.